<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区
          Early 2022
          The National Health Commission asks the country's medical institutions to beef up capacity of infectious diseases prevention and control.
          May 2022
          The State Council’s inter-agency task for COVID-19 response unveils a plan to handle massive outbreak of Omicron variant, stressing the need to enhance treatment capacity of hospitals. ?
          June 28, 2022
          According to the new protocol, the centralized quarantine period for close contacts and inbound travelers is cut from 14 days to seven. Sub-close contacts will undergo seven days of medical observation under home quarantine, instead of seven days of medical observation in isolation at designated sites.
          July 25, 2022
          China’s top drug regulator conditionally approves the first domestic COVID medication Azvudine.
          Nov 10, 2022
          Xi Jinping chairs a Party leadership meeting to hear a report on the COVID-19 response, and discuss and arrange 20 measures to further optimize the responses, calling for more science-based and targeted epidemic responses.
          Nov 11, 2022
          Under the new rules, categories of COVID-risk areas are adjusted to only high and low from the previous categories of high, medium and low to minimize the number of people under quarantine; the centralized quarantine period for inbound travelers and close contacts is reduced from seven days to five; the circuit breaker mechanism for inbound flights is canceled.
          Nov 24, 2022
          The authorities release a circular on work of preparing medical resources for COVID-19 treatment, highlighting efforts to redress unbalanced distribution of medical resources and prepare and train medical workers to brace for more COVID cases.
          Nov 29, 2022
          The authorities issue work plans to step up efforts to vaccinate the seniors and develop triage treatment protocol for vulnerable groups. By Dec 13, over 86 percent of those aged above 60 have been fully vaccinated against COVID-19.
          Dec 6, 2022
          Xi Jinping presides over a top Party meeting, calling for steps to better coordinate epidemic control with socioeconomic development, and better coordinate development with security.
          Dec 7, 2022
          Under the “10 new rules”, a negative nucleic acid testing result is no longer required for domestic travel and entry to public venues, and centralized quarantine for COVID patients is made voluntary; Local authorities are banned from rolling out lockdowns outside individual buildings or floors and blocking entrances.
          Dec 15–16, 2022
          Xi Jinping presides over the Central Economic Working Conference, stressing the need to optimize epidemic response based on the prevailing situation and with focus on the elderly and those with underlying diseases.
          Dec 26, 2022
          The Chinese term for COVID-19 is renamed from “novel coronavirus pneumonia” to “novel coronvirus infection” to more accurately reflect the disease' characteristics.
          Dec 29, 2022
          The top drug regulator conditionally approves oral antiviral pill Molnupiravir.
          Jan 7, 2023
          The new protocol highlights vaccination and personal protection, and improves the diagnostic criteria and warning indicators for severe and critical cases, which will help ensure that limited medical care resources can be concentrated on caring for the most vulnerable.
          Jan 8, 2023
          China downgrades the management of COVID-19 from Class A to Class B and removes it from quarantinable infectious disease management. The further relaxation of COVID controls sees quarantine requirements and COVID-19 testing scrapped for cross-border travelers.
          Jan 29, 2023
          China has granted conditional approval to two homegrown COVID-19 oral pills, the National Medical Products Administration said on Sunday. One is Xiannuoxin and the other is VV116.
          Feb 8, 2023
          The National Healthcare Security Administration said on Wednesday that all domestic COVID-19 medicines have been added to the national medical reimbursement list.
          Joe Biden was sworn in as the 46th president of the United States on Jan 20, taking over a nation hollowed out by a health crisis, an economic recession and a protracted political divide. On Jan 6, Capitol Hill was stormed by Donald Trump's supporters as Congress convened a joint session to certify Biden's victory in the election, leaving five people dead.Joe Biden was sworn in as the 46th president of the United States on Jan 20, taking over a nation hollowed out by a health crisis, an economic recession and a protracted political divide. On Jan 6, Capitol Hill was stormed by Donald Trump's supporters as Congress convened a joint session to certify Biden's victory in the election, leaving five people dead.
          Early 2022
          Nation intensifies infectious diseases control
          The National Health Commission asks the country's medical institutions to beef up capacity of infectious diseases prevention and control.
          May 2022
          Plan rolled out to tackle massive Omicron outbreak
          The State Council’s inter-agency task for COVID-19 response unveils a plan to handle massive outbreak of Omicron variant, stressing the need to enhance treatment capacity of hospitals. ?
          June 28, 2022
          9th edition of COVID control protocol unveiled
          According to the new protocol, the centralized quarantine period for close contacts and inbound travelers is cut from 14 days to seven. Sub-close contacts will undergo seven days of medical observation under home quarantine, instead of seven days of medical observation in isolation at designated sites.
          July 25, 2022
          First domestic oral antiviral pill wins approval
          China’s top drug regulator conditionally approves the first domestic COVID medication Azvudine.
          Nov 10, 2022
          Leadership discusses refining COVID response
          Xi Jinping chairs a Party leadership meeting to hear a report on the COVID-19 response, and discuss and arrange 20 measures to further optimize the responses, calling for more science-based and targeted epidemic responses.
          Nov 11, 2022
          20 optimized COVID control measures released
          Under the new rules, categories of COVID-risk areas are adjusted to only high and low from the previous categories of high, medium and low to minimize the number of people under quarantine; the centralized quarantine period for inbound travelers and close contacts is reduced from seven days to five; the circuit breaker mechanism for inbound flights is canceled.
          Nov 24, 2022
          Medical resources prepared for surge in cases
          The authorities release a circular on work of preparing medical resources for COVID-19 treatment, highlighting efforts to redress unbalanced distribution of medical resources and prepare and train medical workers to brace for more COVID cases.
          Nov 29, 2022
          Efforts redoubled to vaccinate the elderly
          The authorities issue work plans to step up efforts to vaccinate the seniors and develop triage treatment protocol for vulnerable groups. By Dec 13, over 86 percent of those aged above 60 have been fully vaccinated against COVID-19.
          Dec 6, 2022
          Xi calls for better coordination of epidemic control, economic work
          Xi Jinping presides over a top Party meeting, calling for steps to better coordinate epidemic control with socioeconomic development, and better coordinate development with security.
          Dec 7, 2022
          COVID response further optimized with 10 new measures
          Under the “10 new rules”, a negative nucleic acid testing result is no longer required for domestic travel and entry to public venues, and centralized quarantine for COVID patients is made voluntary; Local authorities are banned from rolling out lockdowns outside individual buildings or floors and blocking entrances.
          Dec 15–16, 2022
          Central meeting demands enhanced efforts to protect vulnerable groups
          Xi Jinping presides over the Central Economic Working Conference, stressing the need to optimize epidemic response based on the prevailing situation and with focus on the elderly and those with underlying diseases.
          Dec 26, 2022
          COVID renamed as symptoms become milder
          The Chinese term for COVID-19 is renamed from “novel coronavirus pneumonia” to “novel coronvirus infection” to more accurately reflect the disease' characteristics.
          Dec 29, 2022
          Antiviral pill Molnupiravir approved
          The top drug regulator conditionally approves oral antiviral pill Molnupiravir.
          Jan 7, 2023
          10th edition of COVID-19 protocol released
          The new protocol highlights vaccination and personal protection, and improves the diagnostic criteria and warning indicators for severe and critical cases, which will help ensure that limited medical care resources can be concentrated on caring for the most vulnerable.
          Jan 8, 2023
          Management of COVID-19 downgraded from Class A infectious disease to Class B
          China downgrades the management of COVID-19 from Class A to Class B and removes it from quarantinable infectious disease management. The further relaxation of COVID controls sees quarantine requirements and COVID-19 testing scrapped for cross-border travelers.
          Jan 29, 2023
          Approval for two homegrown COVID-19 pills granted
          China has granted conditional approval to two homegrown COVID-19 oral pills, the National Medical Products Administration said on Sunday. One is Xiannuoxin and the other is VV116.
          Feb 8, 2023
          Domestic COVID drugs added to reimbursement list
          The National Healthcare Security Administration said on Wednesday that all domestic COVID-19 medicines have been added to the national medical reimbursement list.
          Joe Biden was sworn in as the 46th president of the United States on Jan 20, taking over a nation hollowed out by a health crisis, an economic recession and a protracted political divide. On Jan 6, Capitol Hill was stormed by Donald Trump's supporters as Congress convened a joint session to certify Biden's victory in the election, leaving five people dead.Joe Biden was sworn in as the 46th president of the United States on Jan 20, taking over a nation hollowed out by a health crisis, an economic recession and a protracted political divide. On Jan 6, Capitol Hill was stormed by Donald Trump's supporters as Congress convened a joint session to certify Biden's victory in the election, leaving five people dead.
          主站蜘蛛池模板: 精品无码老熟妇magnet| 野花社区www视频日本| 任你躁国产自任一区二区三区| 尤物视频色版在线观看| 国产18禁黄网站禁片免费视频 | 亚洲综合一区二区三区| 国产极品精品自在线不卡| 欧洲精品一区二区三区久久| 久久精品国产蜜臀av| 潮喷失禁大喷水无码| 伊人蕉久影院| 亚洲综合一区二区三区| 狠狠色丁香久久婷婷综合五月| 国产尤物av尤物在线观看| 色偷偷www.8888在线观看| 久久人人妻人人爽人人爽| 五月天免费中文字幕av| 麻豆国产成人AV在线播放| 久天啪天天久久99久孕妇| 精品综合久久久久久97| 色网av免费在线观看| 国产一级av一区二区在线| 不卡国产一区二区三区| av高清无码 在线播放| 久久综合国产精品一区二区| 女性高爱潮视频| 国产亚洲999精品AA片在线爽| 伊人色综合一区二区三区影院视频 | 四虎国产精品永久一区高清| 国产成人精品日本亚洲成熟| 成A人片亚洲日本久久| 国产一区二区三区尤物视频| 大地资源中文第二页日本| 国内精品伊人久久久久影院对白 | 国产超高清麻豆精品传媒麻豆精品 | 日本一区二区三区有码视频 | 欧洲中文字幕国产精品| 国产精品多p对白交换绿帽| 亚洲中文字幕成人综合网| 亚洲精品乱码久久久久久按摩高清| 无码成人一区二区三区|